137 related articles for article (PubMed ID: 37385382)
1. The influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas.
Kjems J; Elisabet Håkansson K; Andrup Kristensen C; Grau Eriksen J; Horsholt Kristensen M; Ivalu Sander Holm A; Overgaard J; Rønn Hansen C; Zukauskaite R; Johansen J; Richter Vogelius I; Friborg J
Radiother Oncol; 2023 Sep; 186():109771. PubMed ID: 37385382
[TBL] [Abstract][Full Text] [Related]
2. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
3. Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study.
Kristensen MH; Sørensen MK; Tramm T; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Lilja-Fischer JK; Holm AIS; Samsøe E; Hansen CR; Zukauskaite R; Overgaard J; Eriksen JG
Radiother Oncol; 2024 Apr; 193():110149. PubMed ID: 38341096
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
7. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
9. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
Adrian G; Carlsson H; Kjellén E; Sjövall J; Zackrisson B; Nilsson P; Gebre-Medhin M
Radiat Oncol; 2022 Jun; 17(1):107. PubMed ID: 35701827
[TBL] [Abstract][Full Text] [Related]
10. Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes.
Mattioli F; Lo Manto A; Miglio M; Serafini E; Rossi D; Valerini S; Tonelli R; Fermi M; Pugliese G; Bertolini F; D'Angelo E; Depenni R; Dominici M; Lohr FRH; Marchioni D
Head Neck; 2023 Jun; 45(6):1406-1417. PubMed ID: 37040549
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
13. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
14. Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors.
Adrian G; Gebre-Medhin M; Nilsson P
Acta Oncol; 2023 Nov; 62(11):1375-1383. PubMed ID: 37682690
[TBL] [Abstract][Full Text] [Related]
15. The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications.
Hussain T; Thangavelu K; Kürten C; Galland L; Höing B; Deuss E; Mattheis S; Lang S; Deuschl C; Forsting M; Dörner N
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5339-5345. PubMed ID: 35781741
[TBL] [Abstract][Full Text] [Related]
16. Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy.
Jaber JJ; Murrill L; Clark JI; Johnson JT; Feustel PJ; Mehta V
Otolaryngol Head Neck Surg; 2015 Aug; 153(2):209-17. PubMed ID: 25917669
[TBL] [Abstract][Full Text] [Related]
17. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Khwaja SS; Baker C; Haynes W; Spencer CR; Gay H; Thorstad W; Adkins DR; Nussenbaum B; Chernock RD; Lewis JS; Wang X
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1132-41. PubMed ID: 27209503
[TBL] [Abstract][Full Text] [Related]
18. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study.
Kjems J; Zukauskaite R; Johansen J; Eriksen JG; Lassen P; Andersen E; Andersen M; Farhadi M; Overgaard J; Vogelius IR; Friborg J
Acta Oncol; 2021 Nov; 60(11):1472-1480. PubMed ID: 34369265
[TBL] [Abstract][Full Text] [Related]
19. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
Hansen CR; Johansen J; Samsøe E; Andersen E; Petersen JBB; Jensen K; Andersen LJ; Sand HMB; Bertelsen AS; Grau C
Radiother Oncol; 2018 Jan; 126(1):43-47. PubMed ID: 28987748
[TBL] [Abstract][Full Text] [Related]
20. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.
Zhu RQ; Zhang YM; Luo XY; Shen WY; Zhu HY
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1467-1478. PubMed ID: 36316576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]